Catalyst Financial Partners LLC Reduces Holdings in HCA Healthcare, Inc. (NYSE:HCA)

Catalyst Financial Partners LLC decreased its stake in shares of HCA Healthcare, Inc. (NYSE:HCA) by 7.1% during the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 821 shares of the company’s stock after selling 63 shares during the quarter. Catalyst Financial Partners LLC’s holdings in HCA Healthcare were worth $334,000 at the end of the most recent reporting period.

Other large investors have also recently made changes to their positions in the company. CreativeOne Wealth LLC acquired a new position in shares of HCA Healthcare in the first quarter valued at about $231,000. Bessemer Group Inc. lifted its stake in HCA Healthcare by 51.2% during the 1st quarter. Bessemer Group Inc. now owns 7,629 shares of the company’s stock valued at $2,543,000 after acquiring an additional 2,584 shares during the period. Empowered Funds LLC increased its stake in shares of HCA Healthcare by 54.3% in the first quarter. Empowered Funds LLC now owns 13,910 shares of the company’s stock worth $4,639,000 after acquiring an additional 4,893 shares during the period. Swedbank AB acquired a new position in HCA Healthcare during the first quarter valued at $95,882,000. Finally, EP Wealth Advisors LLC raised its stake in shares of HCA Healthcare by 1.6% during the 2nd quarter. EP Wealth Advisors LLC now owns 225,146 shares of the company’s stock valued at $72,335,000 after buying an additional 3,516 shares during the last quarter. 62.73% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 8,358 shares of the business’s stock in a transaction dated Thursday, September 12th. The shares were sold at an average price of $385.42, for a total value of $3,221,340.36. Following the sale, the executive vice president now directly owns 29,678 shares in the company, valued at approximately $11,438,494.76. The trade was a 0.00 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Company insiders own 1.60% of the company’s stock.

Wall Street Analysts Forecast Growth

HCA has been the topic of several analyst reports. Wells Fargo & Company raised their target price on HCA Healthcare from $365.00 to $395.00 and gave the stock an “equal weight” rating in a report on Tuesday, October 22nd. KeyCorp dropped their price target on shares of HCA Healthcare from $475.00 to $420.00 and set an “overweight” rating on the stock in a research report on Monday. Wolfe Research raised shares of HCA Healthcare to a “strong-buy” rating in a research note on Thursday, August 29th. Morgan Stanley initiated coverage on HCA Healthcare in a report on Tuesday, September 3rd. They issued an “equal weight” rating and a $427.00 price target for the company. Finally, Royal Bank of Canada boosted their price objective on HCA Healthcare from $378.00 to $405.00 and gave the company an “outperform” rating in a research report on Friday, August 23rd. Five equities research analysts have rated the stock with a hold rating, thirteen have given a buy rating and three have given a strong buy rating to the company’s stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average target price of $379.11.

HCA Healthcare Trading Down 0.7 %

Shares of HCA stock opened at $358.57 on Friday. The company has a current ratio of 1.06, a quick ratio of 0.94 and a debt-to-equity ratio of 27.11. The company’s 50-day moving average price is $393.62 and its 200-day moving average price is $353.85. HCA Healthcare, Inc. has a twelve month low of $223.73 and a twelve month high of $417.14. The stock has a market cap of $92.54 billion, a price-to-earnings ratio of 16.10, a PEG ratio of 1.52 and a beta of 1.67.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, December 27th. Investors of record on Friday, December 13th will be issued a $0.66 dividend. This represents a $2.64 dividend on an annualized basis and a yield of 0.74%. The ex-dividend date of this dividend is Friday, December 13th. HCA Healthcare’s dividend payout ratio is presently 11.85%.

HCA Healthcare Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.